195 related articles for article (PubMed ID: 31836775)
1. Plasma activity of Thioredoxin Reductase as a Novel Biomarker in Gastric Cancer.
Peng W; Zhou Z; Zhong Y; Sun Y; Wang Y; Zhu Z; Jiao W; Bai M; Sun J; Lu J; Yin H
Sci Rep; 2019 Dec; 9(1):19084. PubMed ID: 31836775
[TBL] [Abstract][Full Text] [Related]
2. Value of Combined Detection of Serum CEA, CA72-4, CA19-9 and TSGF in the Diagnosis of Gastric Cancer.
Yin LK; Sun XQ; Mou DZ
Asian Pac J Cancer Prev; 2015; 16(9):3867-70. PubMed ID: 25987051
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance and diagnostic value of serum CEA, CA19-9 and CA72-4 in patients with gastric cancer.
Liang Y; Wang W; Fang C; Raj SS; Hu WM; Li QW; Zhou ZW
Oncotarget; 2016 Aug; 7(31):49565-49573. PubMed ID: 27385101
[TBL] [Abstract][Full Text] [Related]
4. Thioredoxin Reductase as a Novel and Efficient Plasma Biomarker for the Detection of Non-Small Cell Lung Cancer: a Large-scale, Multicenter study.
Ye S; Chen X; Yao Y; Li Y; Sun R; Zeng H; Shu Y; Yin H
Sci Rep; 2019 Feb; 9(1):2652. PubMed ID: 30804354
[TBL] [Abstract][Full Text] [Related]
5. CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer.
Yang AP; Liu J; Lei HY; Zhang QW; Zhao L; Yang GH
Clin Chim Acta; 2014 Nov; 437():183-6. PubMed ID: 25086284
[TBL] [Abstract][Full Text] [Related]
6. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.
Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ
Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459
[TBL] [Abstract][Full Text] [Related]
7. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.
Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H
Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.
Sun Z; Zhang N
World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664
[TBL] [Abstract][Full Text] [Related]
9. Value of Combined Detection of Serum CEA, CA72-4, CA19-9, CA15-3 and CA12-5 in the Diagnosis of Gastric Cancer.
Chen C; Chen Q; Zhao Q; Liu M; Guo J
Ann Clin Lab Sci; 2017 May; 47(3):260-263. PubMed ID: 28667025
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer.
Ychou M; Duffour J; Kramar A; Gourgou S; Grenier J
Dis Markers; 2000; 16(3-4):105-10. PubMed ID: 11381189
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic significance of soluble human leukocyte antigen-G for gastric cancer.
Pan YQ; Ruan YY; Peng JB; Han QY; Zhang X; Lin A; Yan WH
Hum Immunol; 2016 Apr; 77(4):317-24. PubMed ID: 26788811
[TBL] [Abstract][Full Text] [Related]
12. Advances in Molecular Biomarkers for Gastric Cancer.
Zheng TH; Zhao JL; Guleng B
Crit Rev Eukaryot Gene Expr; 2015; 25(4):299-305. PubMed ID: 26559090
[TBL] [Abstract][Full Text] [Related]
13. Plasma thioredoxin reductase: a potential diagnostic biomarker for gastric cancer.
Zhu Y; Hu Y; Zhu X; Zhang J; Yuwen D; Wei X; Tang C; Zhang W
Carcinogenesis; 2022 Sep; 43(8):736-745. PubMed ID: 35709525
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of carcinoembryonic and carbohydrate antigens as cancer biomarkers to monitor palliative chemotherapy in advanced stage gastric cancer.
Abbas M; Ahmed A; Khan GJ; Baig MMFA; Naveed M; Mikrani R; Cao T; Naeem S; Shi M; Dingding C
Curr Probl Cancer; 2019 Feb; 43(1):5-17. PubMed ID: 30172422
[TBL] [Abstract][Full Text] [Related]
15. The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer.
Tocchi A; Costa G; Lepre L; Liotta G; Mazzoni G; Cianetti A; Vannini P
J Cancer Res Clin Oncol; 1998; 124(8):450-5. PubMed ID: 9750022
[TBL] [Abstract][Full Text] [Related]
16. An Alternative Method for Screening Gastric Cancer Based on Serum Levels of CEA, CA19-9, and CA72-4.
Yu J; Zheng W
J Gastrointest Cancer; 2018 Mar; 49(1):57-62. PubMed ID: 28028765
[TBL] [Abstract][Full Text] [Related]
17. Potential diagnostic and prognostic value of plasma long noncoding RNA LINC00086 and miR-214 expression in gastric cancer.
Ji B; Huang Y; Gu T; Zhang L; Li G; Zhang C
Cancer Biomark; 2019; 24(2):249-255. PubMed ID: 30689553
[TBL] [Abstract][Full Text] [Related]
18. Serum Membrane Type 1-Matrix Metalloproteinase (MT1-MMP) mRNA Protected by Exosomes as a Potential Biomarker for Gastric Cancer.
Dong Z; Sun X; Xu J; Han X; Xing Z; Wang D; Ge J; Meng L; Xu X
Med Sci Monit; 2019 Oct; 25():7770-7783. PubMed ID: 31619663
[TBL] [Abstract][Full Text] [Related]
19. High Expression of Serum UCA1 may be a Potential Biomarker for Clinical Diagnosis of Gastric Cancer.
Shan L; Liu C; Ma C
Clin Lab; 2019 Sep; 65(9):. PubMed ID: 31532112
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of CA72-4 as a tumor marker in patients with gastric cancer].
Ubukata H; Katano M; Motohashi G; Kasuga T; Takemura A; Tabuchi T; Tabuchi T
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1821-4. PubMed ID: 14619529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
